Home/Sinopharm/Liu Jingzhen
LJ

Liu Jingzhen

Chairman of the Board

Sinopharm

Sinopharm Pipeline

DrugIndicationPhase
BBIBP-CorVCOVID-19 PreventionApproved
Recombinant Protein COVID-19 VaccineCOVID-19 PreventionApproved
Omicron-specific COVID-19 VaccineCOVID-19 Prevention (Variants)Approved
TCM-based Oncology TherapiesCancer Supportive CarePhase III